Your browser doesn't support javascript.
loading
Autologous tumor lysate/Bacillus Calmette-Guérin immunotherapy as an adjuvant to conventional breast cancer therapy.
Convit, J; Montesinos, H; Oviedo, H; Romero, G; Maccarone, B; Essenfeld, E; Convit, A; Palacios, L E.
Afiliação
  • Convit J; Instituto de Biomedicina Dr. Jacinto Convit, Distrito Capital, Venezuela.
  • Montesinos H; Universidad Simón Bolívar, Sartenejas, Distrito Capital, Venezuela.
  • Oviedo H; Instituto de Biomedicina Dr. Jacinto Convit, Distrito Capital, Venezuela.
  • Romero G; Hospital Oncológico Dr. Luis Razetti, Distrito Capital, Venezuela.
  • Maccarone B; Cirugía General & Mastología, Policlínica Metropolitana, Distrito Capital, Venezuela.
  • Essenfeld E; Anatomía Patológica, Policlínica Metropolitana, Distrito Capital, Venezuela.
  • Convit A; Fundación Jacinto Convit, Caracas, 1071, Venezuela. admin@jacintoconvit.org.
  • Palacios LE; Hospital Oncológico Dr. Luis Razetti, Distrito Capital, Venezuela.
Clin Transl Oncol ; 17(11): 884-7, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26077120
INTRODUCTION: Autologous tumor cell vaccines rely on the concept of preserving an individual's own tumorigenic makeup, expressing its unique set of tumor-associated antigens as well as antigenic elements from the surrounding stroma. These autologous tumor characteristics are usually presented with an immune adjuvant in the hopes of enhancing an immune response. METHODS: The autologous vaccine we used was composed of tumor cells combined with BCG and formalin. Animal safety and toxicity were evaluated using mice tumors for the immunotherapy. A small number of patients with advanced stage breast cancer were recruited for an uncontrolled study, using the vaccine solely or combined with chemotherapy/radiotherapy. RESULTS: The immunotherapy had shown to be safe in mice and humans. Upon a 5-year follow-up, the survival rate was 60 % for the combined treatment. CONCLUSIONS: The data suggest that the combined treatment could be a feasible and safe therapeutic strategy. However, further controlled studies should be conducted.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Adjuvantes Imunológicos / Vacinas Anticâncer / Mycobacterium bovis Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Adjuvantes Imunológicos / Vacinas Anticâncer / Mycobacterium bovis Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article